Erysipelas – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:24:27 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Erysipelas – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A study to evaluate the safety and effectiveness of dalbavancin in patients with erysipelas or limited cellulitis being treated at home. https://clinicaltrials.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-dalbavancin-in-patients-with-erysipelas-and-limited-cellulitis-receiving-outpatient-treatment/ Wed, 29 Apr 2026 15:09:52 +0000 https://clinicaltrials.eu/trial/a-study-to-evaluate-the-safety-and-effectiveness-of-dalbavancin-in-patients-with-erysipelas-and-limited-cellulitis-receiving-outpatient-treatment/ This study focuses on Erysipelas and Cellulitis, which are types of Acute bacterial skin and skin structure infection (ABSSSI). These conditions are infections of the skin and the deeper layers of tissue underneath caused by bacteria. The research aims to evaluate the safety and effectiveness of the drug dalbavancin for treating these infections in an outpatient setting, which means receiving treatment without staying overnight in a hospital.

Participants in the study will receive dalbavancin through an intravenous administration, meaning the medication is delivered directly into a vein via a liquid solution. The study will monitor how well the medicine works to control the infection and track any possible side effects that may occur during the treatment period.

]]> Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs https://clinicaltrials.eu/trial/comparison-of-compression-therapy-alone-versus-compression-therapy-with-phenoxymethylpenicillin-for-preventing-recurrent-erysipelas-in-lower-limbs/ Wed, 29 Apr 2026 15:07:25 +0000 https://clinicaltrials.eu/trial/comparison-of-compression-therapy-alone-versus-compression-therapy-with-phenoxymethylpenicillin-for-preventing-recurrent-erysipelas-in-lower-limbs/ This clinical trial focuses on Recurrent Erysipelas, a bacterial skin infection that repeatedly affects the lower legs. The study aims to determine if using compression therapy alone works as well as using compression therapy combined with the antibiotic phenoxymethylpenicillin to prevent the infection from coming back.

The treatment will involve two different approaches. One group will receive only compression therapy, which involves wearing special tight stockings or bandages on the legs. The other group will receive both compression therapy and phenoxymethylpenicillin tablets taken by mouth. The antibiotic treatment can last up to 12 months.

During the study, which lasts for one year, doctors will monitor how well each treatment works in preventing the infection from returning. They will also look at other factors such as skin health, quality of life, and how often patients use their assigned treatments. This will help determine if using compression therapy alone can be as effective as using both compression and antibiotics together.

]]>